APA (7th ed.) Citation

G, D., J, G., J, S., EJ, D., EB, D., WB, N., . . . T, M. (2023). FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways. Clinical and translational medicine, 13(5), e1223. https://doi.org/10.1002/ctm2.1223

Chicago Style (17th ed.) Citation

G, Dixit, Gonzalez-Bosquet J, Skurski J, Devor EJ, Dickerson EB, Nothnick WB, Issuree PD, Leslie KK, and Maretzky T. "FGFR2 Mutations Promote Endometrial Cancer Progression Through Dual Engagement of EGFR and Notch Signalling Pathways." Clinical and Translational Medicine 13, no. 5 (2023): e1223. https://doi.org/10.1002/ctm2.1223.

MLA (9th ed.) Citation

G, Dixit, et al. "FGFR2 Mutations Promote Endometrial Cancer Progression Through Dual Engagement of EGFR and Notch Signalling Pathways." Clinical and Translational Medicine, vol. 13, no. 5, 2023, p. e1223, https://doi.org/10.1002/ctm2.1223.